- Feasibility, acceptability and preferences for intraperitoneal chemotherapy with paclitaxel and cisplatin after optimal debulking surgery for ovarian and related cancers: an ANZGOG study
-
Blinman P, Gainford C, Donoghoe M, Martyn J, Blomfield , Grant P, Kichenadasse G, Vaughan M, Brand A, Shannon C, Gebski V, Stockler M, Friedlander M
- KMID: 2177878
- J Gynecol Oncol.
- 2013 Oct;24(4):359-366.
- doi: 10.3802/jgo.2013.24.4.359
OBJECTIVE: Intraperitoneal (IP) chemotherapy in women with optimally debulked stage III ovarian cancer has been reported to prolong overall survival, but has not been widely adopted due to concerns about... -
- CITED
-
- Close
- SHARE
-
- Close
